Login to Your Account



BIO CEO & Investor Conference

Prostate Cancer R&D for Drugs Increases Alongside Disease

By Michael Harris


Tuesday, February 15, 2011
NEW YORK – Prostate cancer is a burgeoning disease market, but a recent spate of promising clinical news from the drug development industry is also offering optimism for the potential for an equally growing market for drug approvals to address the disease.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription